Clinical Trial

Developing a Methodological Framework and a Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to develop a methodological framework for clinical practice guidelines (CPGs) related to herb-drug interactions (HDIs). It will also learn barriers and facilitators of disseminating HDI-related CPGs and formulate a dissemination plan. The main questions it aims to answer are: 1. develop a methodological framework for HDI-related CPGs using a Delphi method; 2. identity barriers and facilitators of disseminating HDI-related CPGs through semi-structured interviews and formulate a theory-informed dissemination plan to promote the uptake of CPGs locally and internationally. * Participants in the Delphi survey will engage in a consensus development to determine the framework of HDI-related CPGs, including key characteristics and components of this framework. * Participants in the semi-structured interviews will be interviewed on the following topics: their experiences in searching for evidence and CPGs related to HDIs; barriers and facilitators encountered when obtaining information from existing CPGs; their views on the ideal platform for disseminating HDI-related CPGs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-23.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT07248826
Lead Sponsor Chinese University of Hong Kong
Collaborators: Chinese Medicine Development Fund, Chinese Medicine Hospital, Hong Kong Baptist University, Hong Kong Poison Control Center, Hospital Authority, Memorial Sloan Kettering Cancer Center
Conditions Herb-drug Interactions
Enrollment 40 participants
Start Date 2026-02-01
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-18